5-methyl-N-(4-methylpyrimidin-2-yl)-4-(1H-pyrazol-4-yl)thiazol-2-amine,
ADX88178,
1235318-89-4,
ADX-88178,
ADX88178,
5-methyl-N-(4-methylpyrimidin-2-yl)-4-(1H-pyrazol-4-yl)thiazol-2-amine,
CHEMBL3609729,
4-methyl-N-[5-methyl-4-(1H-pyrazol-4-yl)-2-thiazolyl]-2-Pyrimidinamine,
SCHEMBL369060,
GTPL6238,
KS-000001LF,
ADX 88178,
ADX88178?,
BDBM50116515,
MFCD21340285,
ZINC72188048,
AKOS030228680,
CS-6961,
SB16992,
HY-18654,
DB-020207,
TX-013211,
FT-0756913,
2-PYRIMIDINAMINE, 4-METHYL-N-[5-METHYL-4-(1H-PYRAZOL-4-YL)-2-THIAZOLYL]-,
4-methyl-N-[5-methyl-4-(1H-pyrazol-4-yl)-1,3-thiazol-2-yl]pyrimidin-2-amine,
ADX-88178,1235318-89-4, ADX-88178,ADX 88178,ADX88178,
D05GQH,
MIQNXKWDQRNHAU-UHFFFAOYSA-N,
MGluR4 positive modulators, Addex/Merck,
MGluR4 PAM modulators (oral, Parkinson's disease/anxiety),
2-PyriMidinaMine,4-Methyl-N-[5-Methyl-4-(1H-pyrazol-4-yl)-2-thiazolyl]-,
MGluR4 PAM modulators (oral, Parkinson's disease/anxiety), Addex/Merck & Co,